Diferencia entre revisiones de «Clostridium difficile (peds)»
(Created page with "''This page is for <u>pediatric</u> patients; for adult patients see clostridium difficile.''") |
(Prepared the page for translation) |
||
| (No se muestran 7 ediciones intermedias de 2 usuarios) | |||
| Línea 1: | Línea 1: | ||
''This page is for <u>pediatric</u> patients; for adult patients see [[clostridium difficile]].'' | <languages/> | ||
<translate> | |||
''This page is for <u>pediatric</u> patients; for adult patients see [[Special:MyLanguage/clostridium difficile|clostridium difficile]].'' | |||
==Background== | |||
[[File:Pseudomembranous colitis 1.jpg|thumb|Pseudomembranous colitis with yellow pseudomembranes seen on the wall of the sigmoid colon.]] | |||
*[[Special:MyLanguage/Clostridium|Clostridium]] is a genus of [[Special:MyLanguage/Gram-positive bacteria|Gram-positive bacteria]] | |||
*Most common cause of infectious diarrhea in hospitalized patients | |||
*Use contact isolation if suspect | |||
*Alcohol-based hand sanitizers do not reduce spores, but good hand washing does<ref>Leffler DA and Lamont JT. Clostridium difficile Infection. N Engl J Med. 2015; 372:1539-1548.</ref> | |||
===Pediatric Risk Factors=== | |||
*[[Special:MyLanguage/Antibiotic|Antibiotic]] exposure, particularly [[Special:MyLanguage/penicillins|penicillins]], [[Special:MyLanguage/cephalosporins|cephalosporins]], [[Special:MyLanguage/clindamycin|clindamycin]], [[Special:MyLanguage/fluoroquinolones|fluoroquinolones]] | |||
*[[Special:MyLanguage/PPIs|PPIs]] | |||
*GI feeding tubes | |||
*Comorbidities - cancer, recent surgery, hospitalizations | |||
==Clinical Features== | |||
''Varies according to severity and intrinsic host factors (immunosuppression, etc.).'' | |||
*[[Special:MyLanguage/Diarrhea|Diarrhea]] that develops during antibiotic use or within 2 weeks of discontinuation | |||
*Usually occurs after 7-10 days of antibiotics, as diarrhea before that time is more often poor tolerance to antibiotic | |||
*Recent discharge from hospital | |||
*Profuse watery diarrhea | |||
*[[Special:MyLanguage/Abdominal pain|Abdominal pain]]/tenderness | |||
*[[Special:MyLanguage/Fever|Fever]] | |||
*At the extreme, may present with [[Special:MyLanguage/sepsis|sepsis]] secondary to intestinal perforation or [[Special:MyLanguage/toxic megacolon|toxic megacolon]] | |||
==Differential Diagnosis== | |||
</translate> | |||
{{Diarrhea DDX}} | |||
<translate> | |||
==Evaluation== | |||
[[File:MPX1834 synpic40781.png|thumb|Pseudomembranous colitis from ''C. difficile'' on abdominal CT demonstratin diffuse colonic wall thickening and a shaggy endoluminal contour.]] | |||
[[File:PMC5137169 gr1.png|thumb|Pseudomembranous colitis with (A) Accordion sign in transverse colon (thin arrows). (B) Colonic wall thickness, target sign (thick arrow), peritoneal fluid (thin arrow) and pericolonic fat stranding (arrowhead).]] | |||
===Labs=== | |||
*C. diff toxin assay | |||
**Sn 63-94%, Sp 75-100% | |||
*Culture | |||
**Positive culture only means C. diff present, not necessarily that it is causing disease | |||
===Testing Algorithm=== | |||
''For patients with suspected Clostridium difficile associated diarrhea (CDAD)'' | |||
*'''Low''' suspicion | |||
**Send stool for C. diff toxin assay | |||
***Positive → treat (no further testing indicated) | |||
***Negative → do not treat (no further testing indicated) | |||
*'''High''' suspicion | |||
**Send stool for C. diff toxin assay AND treat empirically | |||
***Positive → treat (no further testing indicated) | |||
***Negative → Consider discussion with ID (false negative tests may occur); eval for other causes of diarrhea | |||
===Repeat testing=== | |||
*Never a need for repeat testing within 7 days of a previous test | |||
*NO NEED to repeat positive tests as symptoms resolve as a “test of cure” | |||
*NO NEED to repeat test soon after initial negative test (more likely to be a false positive test than a true positive test) | |||
===Pediatrics=== | |||
*Testing in infants < 1 year of age not recommended due to high rates of colonization | |||
**~40% of infants < 1 month are colonized and asymptomatic<ref>Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. Jangi S, Lamont JT. J Pediatr Gastroenterol Nutr. 2010 Jul; 51(1):2-7.</ref> | |||
**~15% in infants 6-12 months | |||
**By 2 years of age, normal flora is established, similar to adults<ref>Clostridium difficile Infection in children. Sammons JS, Toltzis P, Zaoutis TE. JAMA Pediatr. 2013 Jun; 167(6):567-73.</ref> | |||
==Management== | |||
*Stop offending antimicrobial agents, if possible | |||
*Initial occurrence and first recurrence of mild-moderate disease:<ref>D'Ostroph AR and So TY. Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value. Infect Drug Resist. 2017; 10: 365–375.</ref> | |||
**PO [[Special:MyLanguage/metronidazole|metronidazole]] 30 mg/kg/d in four divided doses, max 2 g/day | |||
*Severe infection or second recurrence: | |||
**PO [[Special:MyLanguage/vancomycin|vancomycin]] 40 mg/kg/d in four divided doses, max 500 mg/day | |||
**If no improvement after 24-48 hours, oral [[Special:MyLanguage/vancomycin|vancomycin]] max dose may be increased to 2 g/d | |||
**Q6hr IV [[Special:MyLanguage/metronidazole|metronidazole]], 30 mg/kg/d, may be added to intracolonic/enema [[Special:MyLanguage/vancomycin|vancomycin]] for ileus, inability to tolerate PO antibiotics | |||
***1-3 year old -- 250 mg [[Special:MyLanguage/vancomycin|vancomycin]] in 50 mL NS | |||
***4-9 year old -- 375 mg [[Special:MyLanguage/vancomycin|vancomycin]] in 75 mL NS | |||
***> 9 year old -- 500 mg [[Special:MyLanguage/vancomycin|vancomycin]] in 100 mL NS | |||
*Multiple recurrences, other strategies, in consult with pediatric GI: | |||
**May benefit from tapering and pulse oral [[Special:MyLanguage/vancomycin|vancomycin]] over 1.5-2 months, as done in adults | |||
**Consider PO [[Special:MyLanguage/fidaxomicin|fidaxomicin]] in ≥ 6 year old patients at 200 mg twice daily for 10 dats | |||
==Disposition== | |||
*Admit: | |||
**Severe [[Special:MyLanguage/diarrhea|diarrhea]] | |||
**Outpatient antibiotic failure | |||
**Systemic response ([[Special:MyLanguage/fever|fever]], [[Special:MyLanguage/leukocytosis|leukocytosis]], severe [[Special:MyLanguage/abdominal pain|abdominal pain]]) | |||
==[[Special:MyLanguage/Antibiotic Sensitivities|Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | |||
{| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Category''' | |||
| align="center" style="background:#f0f0f0;"|'''Antibiotic''' | |||
| align="center" style="background:#f0f0f0;"|'''Sensitivity''' | |||
|- | |||
| [[Special:MyLanguage/Penicillins|Penicillins]]||[[Special:MyLanguage/Penicillin G|Penicillin G]]||X2 | |||
|- | |||
| ||[[Special:MyLanguage/Penicillin V|Penicillin V]]||X1 | |||
|- | |||
| Anti-Staphylocccal [[Special:MyLanguage/Penicillins|Penicillins]]||[[Special:MyLanguage/Methicillin|Methicillin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Nafcillin|Nafcillin]]/[[Special:MyLanguage/Oxacillin|Oxacillin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cloxacillin|Cloxacillin]]/[[Special:MyLanguage/Diclox.|Diclox.]]||X1 | |||
|- | |||
| Amino-[[Special:MyLanguage/Penicillins|Penicillins]]||[[Special:MyLanguage/AMP|AMP]]/[[Special:MyLanguage/Amox|Amox]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Amox-Clav|Amox-Clav]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/AMP-Sulb|AMP-Sulb]]||X2 | |||
|- | |||
| Anti-Pseudomonal [[Special:MyLanguage/Penicillins|Penicillins]]||[[Special:MyLanguage/Ticarcillin|Ticarcillin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Ticar-Clav|Ticar-Clav]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Pip-Tazo|Pip-Tazo]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Piperacillin|Piperacillin]]||X2 | |||
|- | |||
| [[Special:MyLanguage/Carbapenems|Carbapenems]]||[[Special:MyLanguage/Doripenem|Doripenem]]||X2 | |||
|- | |||
| ||[[Special:MyLanguage/Ertapenem|Ertapenem]]||X2 | |||
|- | |||
| ||[[Special:MyLanguage/Imipenem|Imipenem]]||X2 | |||
|- | |||
| ||[[Special:MyLanguage/Meropenem|Meropenem]]||X2 | |||
|- | |||
| ||[[Special:MyLanguage/Aztreonam|Aztreonam]]||R | |||
|- | |||
| [[Special:MyLanguage/Fluroquinolones|Fluroquinolones]]||[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Ofloxacin|Ofloxacin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Pefloxacin|Pefloxacin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Levofloxacin|Levofloxacin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Moxifloxacin|Moxifloxacin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Gemifloxacin|Gemifloxacin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Gatifloxacin|Gatifloxacin]]||R | |||
|- | |||
| 1st G [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefazolin|Cefazolin]]||X1 | |||
|- | |||
| 2nd G. [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefotetan|Cefotetan]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cefoxitin|Cefoxitin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Cefuroxime|Cefuroxime]]||X1 | |||
|- | |||
| 3rd/4th G. [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefotaxime|Cefotaxime]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Cefizoxime|Cefizoxime]]||R | |||
|- | |||
| ||[[Special:MyLanguage/CefTRIAXone|CefTRIAXone]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Ceftaroline|Ceftaroline]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/CefTAZidime|CefTAZidime]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cefepime|Cefepime]]||R | |||
|- | |||
| Oral 1st G. [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefadroxil|Cefadroxil]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cephalexin|Cephalexin]]||X1 | |||
|- | |||
| Oral 2nd G. [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefaclor|Cefaclor]]/[[Special:MyLanguage/Loracarbef|Loracarbef]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cefproxil|Cefproxil]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cefuroxime axetil|Cefuroxime axetil]]||X1 | |||
|- | |||
| Oral 3rd G. [[Special:MyLanguage/Cephalo|Cephalo]]||[[Special:MyLanguage/Cefixime|Cefixime]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Ceftibuten|Ceftibuten]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Cefpodox|Cefpodox]]/[[Special:MyLanguage/Cefdinir|Cefdinir]]/[[Special:MyLanguage/Cefditoren|Cefditoren]]||X1 | |||
|- | |||
| [[Special:MyLanguage/Aminoglycosides|Aminoglycosides]]||[[Special:MyLanguage/Gentamicin|Gentamicin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Tobramycin|Tobramycin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Amikacin|Amikacin]]||R | |||
|- | |||
| ||[[Special:MyLanguage/Chloramphenicol|Chloramphenicol]]||I | |||
|- | |||
| ||[[Special:MyLanguage/Clindamycin|Clindamycin]]||X1 | |||
|- | |||
| [[Special:MyLanguage/Macrolides|Macrolides]]||[[Special:MyLanguage/Erythromycin|Erythromycin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Azithromycin|Azithromycin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Clarithromycin|Clarithromycin]]||X1 | |||
|- | |||
| Ketolide||[[Special:MyLanguage/Telithromycin|Telithromycin]]||X1 | |||
|- | |||
| Tetracyclines||[[Special:MyLanguage/Doxycycline|Doxycycline]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Minocycline|Minocycline]]||X1 | |||
|- | |||
| Glycylcycline||[[Special:MyLanguage/Tigecycline|Tigecycline]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Daptomycin|Daptomycin]]||X1 | |||
|- | |||
| Glyco/Lipoclycopeptides||[[Special:MyLanguage/Vancomycin|Vancomycin]]||'''S''' | |||
|- | |||
| ||[[Special:MyLanguage/Teicoplanin|Teicoplanin]]||'''S''' | |||
|- | |||
| ||[[Special:MyLanguage/Telavancin|Telavancin]]||'''S''' | |||
|- | |||
| ||[[Special:MyLanguage/Fusidic Acid|Fusidic Acid]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Trimethoprim|Trimethoprim]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/TMP-SMX|TMP-SMX]]||X1 | |||
|- | |||
| Urinary Agents||[[Special:MyLanguage/Nitrofurantoin|Nitrofurantoin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Fosfomycin|Fosfomycin]]||X1 | |||
|- | |||
| Other||[[Special:MyLanguage/Rifampin|Rifampin]]||X1 | |||
|- | |||
| ||[[Special:MyLanguage/Metronidazole|Metronidazole]]||'''S''' | |||
|- | |||
| ||[[Special:MyLanguage/Quinupristin dalfoppristin|Quinupristin dalfoppristin]]||I | |||
|- | |||
| ||[[Special:MyLanguage/Linezolid|Linezolid]]||I | |||
|- | |||
| ||[[Special:MyLanguage/Colistimethate|Colistimethate]]||X1 | |||
|} | |||
==See Also== | |||
*[[Special:MyLanguage/Diarrhea|Diarrhea]] | |||
*[[Special:MyLanguage/Clostridium|Clostridium]] | |||
==References== | |||
<references/> | |||
[[Category:ID]] | |||
[[Category:GI]] | |||
</translate> | |||
Revisión del 21:54 4 ene 2026
This page is for pediatric patients; for adult patients see clostridium difficile.
Background
- Clostridium is a genus of Gram-positive bacteria
- Most common cause of infectious diarrhea in hospitalized patients
- Use contact isolation if suspect
- Alcohol-based hand sanitizers do not reduce spores, but good hand washing does[1]
Pediatric Risk Factors
- Antibiotic exposure, particularly penicillins, cephalosporins, clindamycin, fluoroquinolones
- PPIs
- GI feeding tubes
- Comorbidities - cancer, recent surgery, hospitalizations
Clinical Features
Varies according to severity and intrinsic host factors (immunosuppression, etc.).
- Diarrhea that develops during antibiotic use or within 2 weeks of discontinuation
- Usually occurs after 7-10 days of antibiotics, as diarrhea before that time is more often poor tolerance to antibiotic
- Recent discharge from hospital
- Profuse watery diarrhea
- Abdominal pain/tenderness
- Fever
- At the extreme, may present with sepsis secondary to intestinal perforation or toxic megacolon
Differential Diagnosis
Acute diarrhea
Infectious
- Viral (e.g. rotavirus)
- Bacterial
- Campylobacter
- Shigella
- Salmonella (non-typhi)
- Escherichia coli
- E. coli 0157:H7
- Yersinia enterocolitica
- Vibrio cholerae
- Clostridium difficile
- Parasitic
- Toxin
Noninfectious
- GI Bleed
- Appendicitis
- Mesenteric Ischemia
- Diverticulitis
- Adrenal Crisis
- Thyroid Storm
- Toxicologic exposures
- Antibiotic or drug-associated
- Inflammatory bowel disease
Watery Diarrhea
- Enterotoxigenic E. coli (most common cause of watery diarrhea)[2]
- Norovirus (often has prominent vomiting)
- Campylobacter
- Non-typhoidal Salmonella
- Enteroaggregative E. coli (EAEC)
- Enterotoxigenic Bacteroides fragilis
Traveler's Diarrhea
- Giardia lamblia
- Cryptosporidiosis
- Entamoeba histolytica
- Cyclospora
- Clostridium perfringens
- Listeriosis
- Helminth infections
- Marine toxins
- Ciguatera
- Scombroid poisoning
- Paralytic shellfish poisoning
- Neurotoxic shellfish poisoning
- Diarrheal shellfish poisoning
Evaluation
Labs
- C. diff toxin assay
- Sn 63-94%, Sp 75-100%
- Culture
- Positive culture only means C. diff present, not necessarily that it is causing disease
Testing Algorithm
For patients with suspected Clostridium difficile associated diarrhea (CDAD)
- Low suspicion
- Send stool for C. diff toxin assay
- Positive → treat (no further testing indicated)
- Negative → do not treat (no further testing indicated)
- Send stool for C. diff toxin assay
- High suspicion
- Send stool for C. diff toxin assay AND treat empirically
- Positive → treat (no further testing indicated)
- Negative → Consider discussion with ID (false negative tests may occur); eval for other causes of diarrhea
- Send stool for C. diff toxin assay AND treat empirically
Repeat testing
- Never a need for repeat testing within 7 days of a previous test
- NO NEED to repeat positive tests as symptoms resolve as a “test of cure”
- NO NEED to repeat test soon after initial negative test (more likely to be a false positive test than a true positive test)
Pediatrics
- Testing in infants < 1 year of age not recommended due to high rates of colonization
Management
- Stop offending antimicrobial agents, if possible
- Initial occurrence and first recurrence of mild-moderate disease:[5]
- PO metronidazole 30 mg/kg/d in four divided doses, max 2 g/day
- Severe infection or second recurrence:
- PO vancomycin 40 mg/kg/d in four divided doses, max 500 mg/day
- If no improvement after 24-48 hours, oral vancomycin max dose may be increased to 2 g/d
- Q6hr IV metronidazole, 30 mg/kg/d, may be added to intracolonic/enema vancomycin for ileus, inability to tolerate PO antibiotics
- 1-3 year old -- 250 mg vancomycin in 50 mL NS
- 4-9 year old -- 375 mg vancomycin in 75 mL NS
- > 9 year old -- 500 mg vancomycin in 100 mL NS
- Multiple recurrences, other strategies, in consult with pediatric GI:
- May benefit from tapering and pulse oral vancomycin over 1.5-2 months, as done in adults
- Consider PO fidaxomicin in ≥ 6 year old patients at 200 mg twice daily for 10 dats
Disposition
- Admit:
- Severe diarrhea
- Outpatient antibiotic failure
- Systemic response (fever, leukocytosis, severe abdominal pain)
Antibiotic Sensitivities[6]
See Also
References
- ↑ Leffler DA and Lamont JT. Clostridium difficile Infection. N Engl J Med. 2015; 372:1539-1548.
- ↑ Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
- ↑ Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. Jangi S, Lamont JT. J Pediatr Gastroenterol Nutr. 2010 Jul; 51(1):2-7.
- ↑ Clostridium difficile Infection in children. Sammons JS, Toltzis P, Zaoutis TE. JAMA Pediatr. 2013 Jun; 167(6):567-73.
- ↑ D'Ostroph AR and So TY. Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value. Infect Drug Resist. 2017; 10: 365–375.
- ↑ Sanford Guide to Antimicrobial Therapy 2014
